Von Willebrand factor, ADAMTS13 activity, TNF-α and their relationships in patients with chronic kidney disease.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Experimental and Therapeutic Medicine

• Publication date

  2011-11-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.3892/ETM.2011.432PMID 22969924PMCID PMC3438530
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chronic kidney disease stages 1–3 increase the risk of venous thrombosis

  2010cited by this paper
• ADAMTS13 related markers and von Willebrand factor in plasma from patients with thrombotic microangiopathy (TMA)

  2009cited by this paper
• Variations in the ratio between von Willebrand factor and its cleaving protease during systemic inflammation and association with severity and prognosis of organ failure

  2009cited by this paper
• Von Willebrand Factor in Cardiovascular Disease: Focus on Acute Coronary Syndromes

  2008cited by this paper
• Cytokine pattern and endothelium damage markers in Henoch-Schönlein purpura.

  2008cited by this paper
• Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells

  2008influential reference
• Significance of plasma von Willebrand factor level and von Willebrand factor-cleaving protease activity in patients with chronic renal diseases.

  2008cited by this paper
• ADAMTS13 related markers and von Willebrand factor in plasma from patients with thrombotic microangiopathy (TMA).

  2008influential reference
• Endothelial Activation Markers in Anemic Non-Dialysis Chronic Kidney Disease Patients

  2008cited by this paper
• Cytokine Pattern and Endothelium Damage Markers in Henoch-Schönlein Purpura

  2008cited by this paper
• Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis.

  2007cited by this paper
• Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction.

  2007cited by this paper
• ADAMTS‐13, von Willebrand factor and related parameters in severe sepsis and septic shock

  2007cited by this paper
• Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure.

  2006cited by this paper
• FRETS‐VWF73, a first fluorogenic substrate for ADAMTS13 assay

  2005cited by this paper
• The "cytokine profile": a code for sepsis.

  2005cited by this paper
• Plasma von Willebrand factor, thrombosis, and the endothelium: The first 30 years

  2005cited by this paper
• Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension.

  2004cited by this paper
• The pathophysiology and treatment of sepsis.

  2003cited by this paper
• [Metabolic consequences of inflammation in kidney failure].

  2003cited by this paper
• K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

  2002cited by this paper
• Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines.

  2001cited by this paper
• Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

  2001influential reference
• Endothelial cell and hemostatic activation in relation to cytokines in patients with sepsis.

  1999cited by this paper
• Lupus nephritis.

  1997cited by this paper
• Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

  1992cited by this paper
• von Willebrand factor antigen in plasma and urine in patients with type I (insulin-dependent) diabetes mellitus with and without nephropathy.

  1992cited by this paper
• Lupus Nephritis

  1959cited by this paper
• HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Effects

  year unknowncited by this paper

• Disintegrin‐Like and Metalloprotease With Thrombospondin Type 1 Repeat Motifs 13 (ADAMTS13) Activity in 40 Healthy Dogs

  2025cites this paper
• Frequency of Tumor Necrosis Factor-α, Interleukin-6, and Interleukin-10 Gene Polymorphisms in Mexican Patients with Diabetic Retinopathy and Diabetic Kidney Disease

  2025cites this paper
• The role of cellular senescence in endothelial dysfunction and vascular remodelling in arteriovenous fistula maturation.

  2025cites this paper
• The role of perirenal adipose tissue deposition in chronic kidney disease progression: Mechanisms and therapeutic implications.

  2024cites this paper
• Proteinuria and risk of ocular motor cranial nerve palsy: a nationwide population-based study

  2024cites this paper
• Implications of von Willebrand Factor in Inflammatory Bowel Diseases: Beyond Bleeding and Thrombosis.

  2024cites this paper
• Proteonano™: a novel deep proteomics platform with 1000-plex profiling capacity and picogram sensitivity and its application in diabetic kidney disease

  2023influential citation
• Anticoagulant Treatment in Patients with Atrial Fibrillation and Chronic Kidney Disease: Practical Issues

  2022cites this paper
• Association between ADAMTS13 deficiency and cardiovascular events in chronic hemodialysis patients

  2021cites this paper
• Chronic kidney disease in the pathogenesis of acute ischemic stroke

  2019cites this paper
• Cadmium regulates von Willebrand factor and occludin expression in glomerular endothelial cells of mice in a TNF-α-dependent manner

  2019cites this paper
• Circulating active von Willebrand factor levels are increased in chronic kidney disease and end-stage renal disease

  2019cites this paper
• Plasma von Willebrand Factor and a Disintegrin and Metalloproteinase with Eight Thrombospondin-type 1 Motif Levels in Hemodialysis Patients: Relation to Vascular Access Thrombosis

  2018cites this paper
• Increased levels of circulating (TNF-α) is associated with (-308G/A) promoter polymorphism of TNF-α gene in Diabetic Nephropathy.

  2018cites this paper
• Venous thromboembolism, factor VIII and chronic kidney disease.

  2018cites this paper
• Peptidomics of Body Fluids

  2018cites this paper
• Acute and subacute effect of ferric carboxymaltose on inflammation and adhesion molecules in patients with predialysis chronic renal failure

  2017cites this paper
• Study of A Disintegrin and Metalloproteinasewith ThromboSpondin Type 1 Repeats 13(ADAMTS 13) in Children with IdiopathicNephrotic Syndrome

  2017cites this paper
• Different impact of aspirin on renal progression in patients with predialysis advanced chronic kidney disease with or without previous stroke.

  2017cites this paper
• Vitamin D modulates tissue factor and protease‐activated receptor 2 expression in vascular smooth muscle cells

  2016cites this paper
• Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease.

  2016cites this paper
• HMGB1 facilitates hypoxia‐induced vWF upregulation through TLR2‐MYD88‐SP1 pathway

  2016cites this paper
• von Willebrand Factor, ADAMTS13 Activity, and Decline in Kidney Function: A Population-Based Cohort Study.

  2016cites this paper
• Effects and mechanism of Tripterygium wilfordii on chronic glomerulo nephritis.

  2016cites this paper
• Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of View

  2016cites this paper
• Proteinuria, but Not eGFR, Predicts Stroke Risk in Chronic Kidney Disease: Chronic Renal Insufficiency Cohort Study

  2015cites this paper
• Avaliação da função renal e sua associação com FVW, ADAMTS13 e dímero D em pacientes diabéticos tipo 1

  2014cites this paper
• Tumor necrosis factor alpha -238 G/A and -308 G/A polymorphisms and soluble TNF-α levels in chronic kidney disease: correlation with clinical variables.

  2014cites this paper
• Accelerated Atherosclerosis In Patients With Chronic Kidney Disease - The Role Of Traditional And Non-traditional Risk Factors

  2014cites this paper
• Blocking von Willebrand factor for treatment of cutaneous inflammation.

  2014cites this paper
• Secretion of von Willebrand factor by endothelial cells links sodium to hypercoagulability and thrombosis

  2014cites this paper
• Low-Dose Aspirin for Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease

  2014cites this paper
• Peripheral venous congestion causes inflammation, neurohormonal, and endothelial cell activation.

  2014cites this paper
• Urinary proteomics and molecular determinants of chronic kidney disease: possible link to proteases

  2014cites this paper
• Simvastatin increases ADAMTS13 expression in podocytes.

  2013cites this paper
• Acute and sub-acute effect of ferric carboxymaltose on inflammation and adhesion molecules in patients with predialysis chronic renal failure.

  2013cites this paper
• Efecto agudo y subagudo de la carboximaltosa férrica sobre la inflamación y moléculas de adhesión en pacientes con insuficiencia renal crónica prediálisis

  2013cites this paper
• ADAMTS13: The von Willebrand Factor Cleaving Protease and Its Role in Thrombotic Thrombocytopenic Purpura

  2013cites this paper
• D-dimer, Von Willibrand factor, and ADAMTS13 in renal transplant D-dimer, Von Willibrand factor, and ADAMTS13 in renal transplant recipients recipients

  year unknowncites this paper